School of Health and Related Research, University of Sheffield, Sheffield, UK
Women's Health Academic Centre, Guy's & St Thomas's NHS Foundation Trust, London, UK.
Emerg Med J. 2020 Jul;37(7):423-428. doi: 10.1136/emermed-2019-209213. Epub 2020 Apr 9.
Recent studies suggest that combinations of clinical probability assessment (the YEARS algorithm or Geneva score) and D-dimer can safely rule out suspected pulmonary embolism (PE) in pregnant women. We performed a secondary analysis of the DiPEP (Diagnosis of Pulmonary Embolism in Pregnancy) study data to determine the diagnostic accuracy of these strategies.
The DiPEP study prospectively recruited and collected data and blood samples from pregnant/postpartum women with suspected PE across 11 hospitals and retrospectively collected data from pregnant/postpartum women with diagnosed PE across all UK hospitals (15 February 2015 to 31 August 2016). We selected prospectively recruited pregnant women who had definitive diagnostic imaging for this analysis. We used clinical data and D-dimer results to determine whether the rule out strategies would recommend further investigation. Two independent adjudicators used data from imaging reports, treatments and adverse events up to 30 days to determine the reference standard.
PEs were diagnosed in 12/219 (5.5%) women. The YEARS/D-dimer strategy would have ruled out PE in 96/219 (43.8%) but this would have included 5 of the 12 with PEs. Sensitivity for PE was 58.3% (95% CI 28.6% to 83.5%) and specificity 44.0% (37.1% to 51.0%). The Geneva/D-dimer strategy would have ruled out PE in 46/219 (21.0%) but this would have included three of the 12 with PE. Sensitivity was 75.0% (95% CI 42.8% to 93.3%) and specificity 20.8% (95% CI 15.6% to 27.1%). Administration of anticoagulants prior to blood sampling may have reduced D-dimer sensitivity for small PE.
Strategies using clinical probability and D-dimer have limited diagnostic accuracy and do not accurately rule out all PE in pregnancy. It is uncertain whether PE missed by these strategies lead to clinically important consequences.
最近的研究表明,临床概率评估(YEARS 算法或日内瓦评分)与 D-二聚体的组合可安全排除疑似孕妇肺栓塞(PE)。我们对 DiPEP(妊娠时肺栓塞的诊断)研究数据进行了二次分析,以确定这些策略的诊断准确性。
DiPEP 研究前瞻性地招募并收集了 11 家医院疑似 PE 的孕妇/产后女性的数据和血样,并回顾性地收集了英国所有医院确诊 PE 的孕妇/产后女性的数据(2015 年 2 月 15 日至 2016 年 8 月 31 日)。我们为这项分析选择了前瞻性招募并已行明确诊断性影像学检查的孕妇。我们使用临床数据和 D-二聚体结果来确定排除策略是否建议进一步检查。两名独立的裁决者使用来自影像学报告、治疗和 30 天内不良事件的数据来确定参考标准。
12/219(5.5%)名女性诊断为 PE。YEARS/D-二聚体策略将排除 219 例中的 96 例(43.8%)PE,但其中 5 例为 PE。PE 的敏感性为 58.3%(95%CI,28.6%至 83.5%),特异性为 44.0%(95%CI,37.1%至 51.0%)。Geneva/D-二聚体策略将排除 219 例中的 46 例(21.0%)PE,但其中 3 例为 PE。敏感性为 75.0%(95%CI,42.8%至 93.3%),特异性为 20.8%(95%CI,15.6%至 27.1%)。在采血前使用抗凝剂可能会降低小 PE 时 D-二聚体的敏感性。
使用临床概率和 D-二聚体的策略诊断准确性有限,不能准确排除所有妊娠时的 PE。这些策略漏诊的 PE 是否会导致临床重要后果尚不确定。